REG - BkofA Merrill Lynch Spire Healthcare Grp - Form 8.5 (EPT/RI) <Origin Href="QuoteRef">SPI.L</Origin>
RNS Number : 8496UBank of America Merrill Lynch27 October 2017FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1.
KEY INFORMATION
(a)
Name of exempt principal trader:
Bank of America Merrill Lynch
(b)
Name of offeror/offeree in relation to whose
relevant securities this form relates:
Use a separate form for each offeror/offereeSpire Healthcare Group PLC
(c)
Name of the party to the offer with which exempt principal trader is connected:
Spire Healthcare Group PLC
(d)
Date dealing undertaken:
26/10/2017
(e)
In addition to the company in 1(b) above, is the
exempt principal trader making disclosures in
respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"YES
If YES, specify which:
(Mediclinic International PLC)
2.
DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class
of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a)
Purchases and sales
Class of relevant security
Purchases/
salesTotal number of securities
Highest price
per unit
paid/receivedLowest price
per unit
paid/receivedCommon - ISIN GB00BNLPYF73
Purchase
1,235,883
2.979 GBP
2.912 GBP
Common - ISIN GB00BNLPYF73
Sale
3,248,628
2.997 GBP
2.905 GBP
(b)
Cash-settled derivative transactions
Class of
relevant securityProduct description
e.g. CFDNature of dealing
e.g. opening/closing a
long/short position, increasing/reducing a
long/short positionNumber of reference securities
Price per unit
Common - ISIN GB00BNLPYF73
Swaps
Long
177,432
2.997 GBP
Common - ISIN GB00BNLPYF73
Swaps
Short
232,758
2.94 GBP
Common - ISIN GB00BNLPYF73
Swaps
Short
71,980
2.94 GBP
(c)
Stock-settled derivative transactions (including options)
(i)
Writing, selling, purchasing or varying
Class
of
relevant securityProduct description e.g. call option
Writing, purchasing, selling, varying etc.
Number
of
securities to which option relatesExercise
price
per unitType
e.g. American, European etc.Expiry date
Option money paid/ received per unit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercise
Class of relevant security
Product description
e.g. call optionExercising/
exercised
againstNumber of
securitiesExercise Price per
unitN/A
N/A
N/A
N/A
N/A
(d)
Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversionDetails
Price per unit (if applicable)
N/A
N/A
N/A
N/A
3.
OTHER INFORMATION
(a)
Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"None
(b)
Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"None
Date of disclosure:
27/10/2017
Contact name:
Harshini Gopa
Telephone number:
+44207 996 3410
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information
Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's
dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNSThe company news service from the London Stock ExchangeENDFERBGBDGDXDBGRR
Recent news on Spire Healthcare
See all newsREG - eEnergy Group PLC Spire Healthcare Grp - Major Contract Win with Spire Healthcare
AnnouncementREG - Spire Healthcare Grp - Capital Markets Event
AnnouncementREG - Spire Healthcare Grp - Notice of AGM
AnnouncementREG - Spire Healthcare Grp - Block listing Interim Review
AnnouncementREG - Spire Healthcare Grp - Portfolio management: Spire Tunbridge Wells
Announcement